Cranial Technologies partnered with Eurazeo

Overview

Deal Type Mergers & Acquisitions
Client & Transactional Partners Cranial Technologies
BPOC
Eurazeo
Our Role Sell-Side Advisor

Summary

Cranial Technologies has announced that Eurazeo has acquired the company from BPOC. BPOC initially invested in Cranial Technologies in May 2017 to accelerate de novo clinic development throughout the U.S. Since that time, BPOC and the Cranial team have recruited a new CEO and CFO, positioned the business for international expansion, opened a new and expanded manufacturing facility, added presence in nine new states and more than doubled the number of clinic locations.

Cain Brothers has represented the Company since 2011 and this transaction is the third successful recapitalization in which Cain Brothers has been the exclusive financial advisor for Cranial Technologies. Cain Brothers’ deep knowledge of the business as well as relationships with a broad universe of buyers were critical in finding partners who have each successfully collaborated with management to grow the Company.

Founded in 1986, Cranial Technologies has provided plagiocephaly treatment to over 300,000 babies in 80 U.S. treatment centers. The company’s mission is to provide the best possible treatment, experience and outcome for every family who seeks care. Cranial Technologies invented the DOC Band®, the first FDA-cleared cranial orthotic, and the DSi® (Digital Surface Imaging) system.

Eurazeo is a global investment company, with a diversified portfolio of €27 billion in assets under management, including nearly €19.2 billion from third parties, invested in 450 companies. With its considerable private equity, venture capital, private debt as well as real estate and infrastructure asset expertise, Eurazeo accompanies companies of all sizes, supporting their development through the commitment of its nearly 300 professionals and by offering deep sector expertise, a gateway to global markets, and a responsible and stable foothold for transformational growth.

Founded in 1996, BPOC is a Chicago-based private equity firm that invests exclusively in healthcare companies and is one of the nation's most experienced investors in the industry, having raised five funds with total capital commitments of nearly $1.8 billion. BPOC has invested in numerous provider, manufacturing, outsourcing, distribution, and information technology companies through growth equity, management buyouts, and leveraged recapitalizations. For more information, please visit www.bpoc.com.

Cain Brothers

Cranial Technologies Eurazeo

Recent Deals

April 2025

smartstop self storage reit

$931.5 Million

Initial Public Offering

Active Bookrunner

smartstop-self-storage-reit
March 2025

catawabanationtwokings

$1.025 Billion

Senior Secured Credit Facilities

Joint Lead Arranger
Joint Bookrunner

catawba-nation-gaming-authority
March 2025

prairie operating

$43.8 Million

Follow-On Offering

$148.3 Million

Series F Convertible Preferred Stock Offering

$1 Billion

Senior Secured Revolving Credit Facility

Joint Bookrunner
Capital Markets Advisor
Joint Lead Arranger

prairie-operating-co
March 2025

integer

$1 Billion

Convertible Senior Notes due 2030

Co-Manager

integer

Connect With Us

Find an Expert